Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:Thomas_J._Appio
|
| gptkbp:country |
gptkb:Canada
|
| gptkbp:CUSIP |
071734107
|
| gptkbp:foundedYear |
1959
|
| gptkbp:headquartersLocation |
gptkb:Laval,_Quebec,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
NYSE:BHC
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:ISIN |
CA0717341071
|
| gptkbp:listedOn |
gptkb:New_York_Stock_Exchange
|
| gptkbp:market |
gptkb:NYSE
|
| gptkbp:numberOfEmployees |
~7000 (2023)
|
| gptkbp:operates |
gptkb:Bausch_Health_Companies_Inc.
|
| gptkbp:previousName |
gptkb:Valeant_Pharmaceuticals_International,_Inc.
|
| gptkbp:product |
pharmaceuticals
medical devices over-the-counter products |
| gptkbp:sector |
gptkb:insurance
|
| gptkbp:stockSymbol |
gptkb:BHC
|
| gptkbp:subsidiary |
gptkb:Solta_Medical
gptkb:Bausch_+_Lomb gptkb:OraPharma gptkb:Salix_Pharmaceuticals gptkb:Dendreon_Pharmaceuticals |
| gptkbp:tradedOn |
gptkb:NYSE:BHC
gptkb:TSX:BHC |
| gptkbp:website |
https://www.bauschhealth.com/
|
| gptkbp:bfsParent |
gptkb:Bausch_Health_Companies
|
| gptkbp:bfsLayer |
6
|